Next Article in Journal
Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview
Next Article in Special Issue
An Optimization of Oregano, Thyme, and Lemongrass Essential Oil Blend to Simultaneous Inactivation of Relevant Foodborne Pathogens by Simplex–Centroid Mixture Design
Previous Article in Journal
Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa
Previous Article in Special Issue
Gelidiales Are Not Just Agar—Revealing the Antimicrobial Potential of Gelidium corneum for Skin Disorders
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of β-Glucan Supplementation on Growth Performance and Intestinal Epithelium Functions in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli

1
Animal Nutrition Research Institute, Sichuan Agricultural University, Chengdu 611130, China
2
Key Laboratory of Animal Disease-Resistance Nutrition, Chengdu 625014, China
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(4), 519; https://doi.org/10.3390/antibiotics11040519
Submission received: 15 March 2022 / Revised: 10 April 2022 / Accepted: 11 April 2022 / Published: 13 April 2022
(This article belongs to the Special Issue Green Antimicrobials)

Abstract

:
Background: To examine the effect of β-glucan (BGL) supplementation on growth performance and intestinal epithelium functions in weaned pigs upon Enterotoxigenic Escherichia coli (ETEC) challenge. Methods: Thirty-two weaned pigs (Duroc × Landrace × Yorkshire) were assigned into four groups. Pigs fed with a basal diet or basal diet containing 500 mg/kg BGL were orally infused with ETEC or culture medium. Results: Results showed BGL tended to increase the average daily gain (ADG) in ETEC-challenged pigs (0.05 < p < 0.1). Dietary BGL supplementation had no significant influence on nutrient digestibility (p > 0.05). However, BGL improved the serum concentrations of immunoglobulin (Ig) A and IgG, and was beneficial to relieve the increasement of the concentrations of inflammatory cytokines such as the TNF-α and IL-6 upon ETEC-challenge (p < 0.05). Interestingly, BGL significantly increased the duodenal, jejunal and ileal villus height, and increased the jejunal ratio of villus height to crypt depth (V/C) upon ETEC challenge (p < 0.05). BGL also increased the activities of mucosal, sucrase and maltase in the ETEC-challenged pigs (p < 0.05). Moreover, BGL elevated the abundance of Lactobacillus and the concentration of propanoic acid in colon in the ETEC-challenged pigs (p < 0.05). Importantly, BGL elevated the expression levels of zonula occludins-1 (ZO-1) and mucin-2 (MUC-2) in the small intestinal mucosa upon ETEC challenge (p < 0.05). BGL also upregulated the expressions of functional genes such as the claudin-1, cationic amino acid transporter-1 (CAT-1), LAT-1, L amino acid transporter-1 (LAT1), fatty acid transport proteins (FATP1), FATP4, and sodium/glucose cotransporter-1 (SGLT-1) in the duodenum, and the occludin-1 and CAT-1 in the jejunum upon ETEC challenge (p < 0.05). Conclusions: These results suggested that BGL can attenuate intestinal damage in weaned pigs upon ETEC challenge, which was connected with the suppressed secretion of inflammatory cytokines and enhanced serum immunoglobulins, as well as improved intestinal epithelium functions and microbiota.

1. Introduction

Weaning is a critical challenge for mammalian animals including pigs. Abrupt changes in diet form and removal of the passive maternal protection in post-weaning piglets increases their susceptibility to diarrhea, resulting in a certain degree of damage to the intestinal structure and mucosal barrier functions [1,2]. ETEC is one of the most critical bacterial causes of intestinal diarrhea [3]. Upon adhering to the intestinal epithelium with their fimbriae, ETEC produces various enterotoxins that can take effect on the small intestinal epithelium and cause the secretion of fluids and electrolytes, which can lead to diarrhea [4]. Over the previous few decades, antibiotics have been extensively used to relieve diarrhea resulting from various bacteria and weaning stress in pig production [5,6]. However, drug residues in the product and the bacterial resistance against classical antibiotics are growing problems all over the world, and it is urgent to develop alternatives to traditionally used antibiotics [7,8].
The most extensive studied alternatives include probiotics, prebiotics, enzymes, acidifiers, and plant extracts [9]. Among the feed additives applied in pigs, prebiotics are regarded as preferable, since they can accelerate competitive exclusion of pathogenic microorganisms and selectively promote the colonization of beneficial microbes [10]. Among the known prebiotics, the mannan-oligosaccharide (MOS) and fructo-oligosaccharide (FOS) have been extensively tested in swine and poultry [11,12]. For instance, both in vivo and in vitro studies showed that in the presence of MOS and FOS, the enteric pathogens do not adhere to the epithelium but to the sugar compounds in the enterocoel, which obviously deceased their colonization and intestinal inflammation [13,14,15].
β-glucan (BGL) has also been known as an important natural prebiotic that is abundant in lentinan, cereals, and the yeast cell wall [16]. β-(1,3)-glucan can form a triple helix structure, which can facilitate the interaction of molecules and receptors and induce a biological effect. Because of the deficiency of β-glucanase in animals, BGL can escape the enzymatic digestion from the upper gastrointestinal tract and enter the hindgut as a fermentation substrate for microorganisms. Previous studies indicated that BGL can selectively stimulate the growth of beneficial bacteria and help to maintain the intestinal health [17,18]. Moreover, the immunomodulatory effects of BGL have also been well documented [19,20]. For instance, BGL isolated from the yeasts considerably promoted the production of serum cytokines and IgA in hens [21]. It is well known that differences in molecular weight and branching degree of glucan affect the solubility of BGL, which may ultimately affect their immune-modulating properties [22]. As compared to those without branches, BGLs consist of a (1,3)-β-linked backbone with β-(1,6) showed a higher immunomodulatory activity [23]. BGL can also act as a pathogen associated molecular pattern (PAMP), and dectin-1 is the main recognition receptor that is highly expressed in macrophages and dendritic cells [24].
Although numerous studies have indicated a positive role of BGL in regulating the intestinal health and immune functions, data regarding the effect of BGL on the intestinal epithelium functions of the weaned pig exposure to ETEC are scarce. The aim of this study was to examine whether dietary BGL supplementation could relieve ETEC-induced intestinal inflammation and epithelium damage in weaned pigs. This study will also help in the understanding of the mechanisms behind the BGL-regulated intestinal health.

2. Results

2.1. Effect of BGL on Growth Performance and Nutrients Digestibility in Weaned Pigs upon ETEC Challenge

As shown in Table 1, no significant differences were observed on ADFI, ADG and F: G among all groups before the ETEC challenge (p > 0.05). However, ETEC challenge significant decreased the ADG in the weaned pigs (p < 0.05). BGL supplementation relieved the decrement of daily gain (ADG), but there was no significant difference in the ETEC-challenged pigs (p > 0.05). In addition, no significant differences were observed on the four treatments for nutrients digestibility (Table 2).

2.2. Effect of BGL on Serum Immunoglobulins and Inflammatory Cytokines in Weaned Pigs upon ETEC Challenge

As shown in Figure 1, BGL supplementation increased the concentration of IgA in the non-challenged as well as in the ETEC-challenged pigs (p < 0.05). BGL supplementation increased the concentration of IgG in the ETEC-challenged pigs (p < 0.05). ETEC enhanced the concentration of IL-1β and IL-6 in the serum (p < 0.05). However, BGL supplementation greatly relieved the improvement of the concentration of TNF-α and IL-6 caused by the ETEC challenge (p < 0.05).

2.3. Effect of BGL Supplementation on Intestinal Morphology and Mucosal Enzyme Activity in Weaned Pigs upon ETEC Challenge

As shown in Table 3 and Figure 2, ETEC challenge acutely reduced the jejunal villus height (p < 0.01). Nevertheless, pigs fed with BGL supplementation enormously improved the jejunal villus height and the ratio of V/C upon ETEC challenge (p < 0.05). Furthermore, BGL supplementation also enhanced duodenal and ileal villus height upon ETEC challenge (p < 0.05). ETEC challenge decreased the activities of maltase, lactase, and sucrase in the jejunum (Table 4). However, BGL supplementation significantly relieved the reduction of their activities upon ETEC challenge (p < 0.05). BGL supplementation also enhanced the duodenal and ileal activity of maltase upon ETEC challenge (p < 0.05).

2.4. Effect of BGL Supplementation on Expressions of Critical Genes Involved in Intestinal Epithelium Functions

As shown in Figure 3, the ileal expression levels of ZO-1 obviously decreased upon ETEC challenge (p < 0.05). Conversely, BGL supplementation greatly increased the duodenal, jejunal and ileal expression levels in the ETEC-challenged pigs (p < 0.05). Pigs fed with BGL improved the duodenal expression levels of claudin-1 and jejunal expression levels of occludin upon ETEC challenge (p < 0.05). Moreover, BGL elevated the expression levels of functional genes such as the MUC2, CAT1, LAT1, FATP1, and FATP4 in the duodenum, and increased the jejunal expression levels of MUC2 and CAT1 upon ETEC challenge (p < 0.05).

2.5. Effect of BGL Supplementation on Intestinal Microbial Populations in Weaned Pigs upon ETEC Challenge

ETEC challenge enriched the abundance of Escherichia coli in cecum (p < 0.05). BGL supplementation excellently enhanced the abundance of Lactobacillus upon ETEC challenge (p < 0.05). BGL supplementation also improved the concentration of propanoic acid in the ETEC-challenged pigs (Table 5).

3. Discussion

As a commercially feasible prebiotic, BGL can escape from enzymatic digestion in the upper intestine, but can be fermented by various microorganisms in the hindgut to produce various short-chain fatty acids that contribute to the maintenance of the intestinal health [25,26]. Importantly, the BGL has long been known as a stimulator of cellular immunity [27]. In this study, the ETEC challenge significantly reduced the ADG in the weaned pigs, but BGL had a tendency to increase the ADG in the ETEC-challenged pigs. The beneficial effects of dietary BGL supplementation on growth performance have also been observed in previous studies using different animal species [28,29,30].
Immunoglobulins, also known as antibodies, were a class of glycoproteins secreted by plasma cells. They play a key role in the immune response, and they can specifically recognize and bind to particular antigens, such as bacteria or viruses, and assist with their destruction. Currently, five classes (isotypes) of immunoglobulins (IgM, IgG, IgA, IgD, and IgE), were identified according to their heavy chain subunits [31]. Amongst the five classes, IgG is the primary immunoglobulin in serum, which can promote phagocytosis of mononuclear macrophages and neutralize the toxicity of bacterial toxins [32], whereas IgA is the second abundant immunoglobulin in serum [33]. In this study, BGL supplementation maintained a high level of serum IgA and IgG upon ETEC challenge, indicating an immune enhancement in the pigs upon ETEC challenge. As several common pro-inflammatory cytokines, TNF-α, IL-1β and IL-6, are widely considered as the biomarkers of inflammatory response or inflammation [34]. In the present study, the concentrations of them in the serum were elevated upon ETEC challenge, which is consistent with previous studies on pigs [12,15]. However, BGL supplementation greatly relieved the increase of the serum concentration of the TNF-α and IL-6 upon ETEC challenge.
The intestinal tract is the foremost functional site for monogastric animals to digest and absorb nutrients. The intestinal mucosa villus height and crypt depth are popular indexes to characterize intestinal morphology [35]. However, the intestinal morphology can be impaired upon various bacterial or viral infections [36,37]. In this study, the jejunal villus height was significantly reduced upon ETEC challenge, a finding that is in agreement with current studies on pigs [38]. However, BGL supplementation increased the jejunal villus height and the ratio of V/C upon ETEC challenge. Moreover, BGL treatment both elevated the jejunal mucosa liveness of lactase, sucrase, and maltase upon ETEC challenge. The beneficial effect of BGL on gut health may result from its sugar-chain structure, as a wide variety of prebiotics were shown to prevent enteric pathogens (e.g., ETEC) from attaching to the sugar compounds in the intestinal epithelium, which efficaciously cut down their colonization and intestinal inflammation [39,40,41]. Moreover, the BGL suppressed production of inflammatory factors (for example TNF-α and IL-6) and might also contribute to the improved integrity of the intestinal epithelium upon ETEC challenge, as they were previously reported to induce mucosa atrophy and apoptosis of the intestinal epithelial cells [42].
Tight junctions (TJ) are crucial to retaining the intestinal barrier, and disruption of the intestinal TJ may result in elevated permeability of the intestinal epithelium and entering of harmful substances into the blood [43,44]. In the present study, in pigs challenged with ETEC, the expression levels of the major TJ protein ZO-1 in duodenum and ileum were reduced; however, BGL supplementation significantly increased their expression levels. Moreover, BGL also improved claudin-1 and occludin expression levels in the duodenum and jejunum upon ETEC challenge, respectively. Claudin-1 and occludin are another two critical TJ proteins which are widely expressed in epithelial tissues. A previous study has shown that claudin-1- deficient mice died due to skin wrinkling, severe dehydration and an increase in epidermal permeability [45]. Occludin promotes the formation of reticular TJs and reduces the permeability of ions and macromolecules to enhance the intestinal barrier [46]. The elevation of their expression levels by BGL supplementation indicated an improved integrity of the intestinal barrier upon ETEC challenge. We also explored the expression levels of several key molecules that are associated with the intestinal barrier functions. MUC2 is a major intestinal secretory mucin and acts as a major component of the mucus layer. Importantly, the MUC2 was found to limit the intestinal luminal load by protecting against the accumulation of some less-adherent pathogens (A/E bacteria) [47]. Moreover, the generation of NO is extremely dependent on L-arginine, and the CAT1 is a major L-arginine transmembrane transporter in endothelial cells [48]. In this study, the jejunal expression levels of MUC2 and CAT1 was significantly improved due to BGL treatment after ETEC-challenge. In addition, the duodenal expression levels of LAT1 and FATP4 showed the same result. The LAT1 is one of the major bidirectional transporters of large neutral amino acids, and is responsible for the transportation of Leu into muscle cells [49], whereas the FATP4 is responsible for the uptake of long-chain fatty acids [50]. Elevated expressions of these critical functional genes indicated that BGL treatment is beneficial to enhance intestinal integrity and epithelial functions in weaned piglets under ETEC challenge.
The impact of the intestinal microbiota on health and disease is increasingly emerging. Like with other prebiotics, BGLs are resistant to enzymatic hydrolysis in the small intestine, and thence the majority enters the large intestine in an integral form [51]. In this experiment, BGL supplementation increased the abundance of Lactobacillus in the cecum upon ETEC challenge. The Lactobacillus is one of the most critical beneficial microorganisms in the gut, which is not only capable of promoting secretion of sIgA from the lamina propria to the surface of the intestinal epithelium, but also capable of activating the macrophages via the TLR2 signaling pathway [52,53]. Prebiotics can be used as substrate for microbial fermentation, causing production of various SCFAs (e.g., acetate, propionate, butyrate) [54]. A previous study has indicated that SCFAs can suppress the ETEC infection in the intestine by reducing virulence gene expression, flagella movement, and colonization [55]. Moreover, the concentration of propanoic acid was elevated by BGL upon ETEC challenge. The increased concentration of propanoic acid was found to increase blood flow and thereby promote the proliferation of intestinal epithelial cells [56]. Moreover, propanoic acid can also enhance the intestinal barrier by increasing the TJs expression levels, such as claudin-1, claudin-8, and occludin [57]. The present experiment was approved a potential mechanism by which the BGL-improved intestinal barrier functions.

4. Materials and Methods

The animal experiment was approved by the Institutional Animal Care and Use Committee of Sichuan Agricultural University (No. 20181105). Glucan product (β-glucan ≥ 60%) was kindly provided by SYNLGHT BIO Co., Ltd. (Guangzhou, China) Pathogenic Escherichia coli (ETEC, O149:K91, K88ac) was purchased from the China veterinary culture collection center with a CVCC no. 225 (Beijing, China).

4.1. Animal Diets and Experimental Design

A total of 32 commercial piglets (DLY) weaned at 21 d (with an average body weight of 6.82 ± 0.16 kg) were blocked by weight and allocated as a 2 (BGL) × 2 (ETEC) factorial design to four treatments (n = 8) composed of CON (the basal diet), BGL (500 mg/kg BGL) and ECON (the basal diet and challenged by ETEC), EBGL (500 mg/kg BGL and challenged by ETEC). The basal diet (Table 6) was designed to satisfy the swine nutrient requirements recommended byNRC2012 [58]. Pigs were individually housed in 1.5 × 0.7 m2 metabolism cages and had free access to feed and water. The temperature was controlled between 27–30 °C and the relative humidity was kept at 65 ± 5%. The experiment lasted for 28 d. The ETEC-challenged pigs were orally infused with 100 mL Luria-Bertani (LB) medium (containing 1 × 1010 CFU/mL ETEC) on day 26, and other pigs were infused with an equal volume of LB medium.

4.2. Growth Performance Evaluation

Piglets were weighed on day 1, 26, and 29 after 12 h fasting. The average daily gain (ADG), average daily feed intake (ADFI), and feed efficiency (F/G) were calculated by recording the feed intake and body weight gain during the experimental period.

4.3. Sample Collection

Uncontaminated fecal samples were collected straightway after defecation on days 22 to 25, and mixed with 10% H2SO4 (10 mL H2SO4 per 100 g of fresh fecal) and 1–2 drops of toluene. The four feeds and uncontaminated fecal samples were dried at 65 °C until constant weight, and then stored in powder form of a size that it could pass through a 1-mesh screen. On day 29, blood samples were collected by precaval vein puncture, and serum samples were centrifuged at 3500× g for 15 min after standing for 30 min at 4 °C, fecal and serum samples were stored at –20 °C until the next analysis. After blood collection, the pigs were anesthetized by intravenous injection with sodium pentobarbital (200 mg/kg BW), and segments of the duodenum, jejunum and ileum (about 2–4 cm in the middle sections) were isolated and rinsed softly with phosphate buffered saline (PBS), and then fixed in 4% paraformaldehyde solution for intestinal morphological analysis. Moreover, cecal digesta samples were collected into sterile tubes, and the duodenal, jejunal, and ileal mucosa samples were scraped with a glass slide and quick-freeze using liquid N2, followed by the preservation at −80 °C until further analysis.

4.4. Apparent Total Tract Nutrient Digestibility Analysis

Diet and fecal samples were used for the nutrient digestibility analysis, and the acid insoluble ash (AIA) was regarded as an endogenous indicator. The dry matter (DM), crude protein (CP), ether extract (EE), and Ash contents were measured according to AOAC methods [59]. Moreover, the gross energy (GE) was measured by an adiabatic bomb calorimeter (LECO, St. Joseph, MI, USA). All apparent digestibility of nutrients were calculated by the following formula:
Apparent   digestibility   of   a   nutrient   ( % ) = 100 100 × digesta   nutrient   ×   diet   AIA   diet   nutrient   ×   digesta   AIA

4.5. Serum Proinflammatory Cytokines and Immunoglobulin Detection

The concentration of proinflammatory cytokines (TNF-α, IL-1β and IL-6) and immunoglobulin (IgG, IgM, and IgA) in serum were determined by Enzyme Linked Immunosorbent Assay (ELISA) kits (Shanghai Meimian Biotechnology Co., Ltd., Shanghai, China). There was less than 10% variation of intra-assay and 12% variation of inter-assay coefficients for each assay.

4.6. Histomorphology Analysis of Each Intestinal Segment

The intestinal segment fixed with 4% paraformaldehyde was dewaxed by graded anhydrous ethanol, then stained with hematoxylin and eosin (H&E), dehydrated by graded anhydrous ethanol again, and then sealed with neutral resin. Finally, the crypt depth and villus height of the samples were calculated using an image processing and analysis system (Image-Pro Plus 6.0), and their V/C was calculated. The procedure and statistical method of histomorphology analysis were followed by Wan’s. A total of 10 intact, well-oriented villus heights and corresponding crypt depths were obtained per section, and each intestinal segment was analyzed in triplicate [60].

4.7. Enzyme Activity

Using the frozen saline as the homogenization medium, the duodenal, jejunal and ileal mucosa were made into 10% homogenate, and then the supernatants were collected after centrifugation at 4000× g for 20 min. The lactase, maltase and sucrase were determined by the method of enzyme linked immunosorbent assay (ELISA), and the kits purchased from Shanghai Enzyme-linked Bio-technology Co., Ltd. (Shanghai, China), and kits as follows: lactase (Porcine Lactase ELISA Kit ml712060), sucrase (Porcine Sucrase ELISA Kit ml712026), and maltase (Porcine Maltase ELISA Kit ml712030). All procedures were performed according to the instructions of the kits.

4.8. Caecal Microbiological Analysis

About 0.2 g cecum digesta was processed using the Stool DNA Kits (Omega Bio-Tek, Doraville, CA, USA) to total DNA extraction for quantification real-time PCR, which was executed by conventional PCR on the CFX96 Real-Time PCR Detection system (Bio-Rad Laboratories, Hercules, CA, USA). Total bacteria were assessed by the reaction which runs in a total volume of 25 μL with 12.5 μL SYBR Premix Ex Taq (2× concentrated), 1 μL of forward and reverse primers respective (100 nM), 2 μL DNA, and 8.5 μL of RNase-Free ddH2O. This application program entailed 95 °C for 25 s; followed by 40 cycles of 95 °C for 5 s and 64.5 °C for 25 s; and then a final melting-curve for SYBR Green tests. Lactobacillus, E. coli, Bacillus and Bifidobacterium were tested by the SuperReal PreMix (Probe) kit (Tiangen Biotech Co., Ltd., Beijing, China). The reaction run in a total volume of 20 μL with 10 μL 2 × Super Real PreMix (Probe), 0.6 μL of forward and reverse primers (100 nM) respective, 0.4 μL probe (100 nM), 2 μL DNA and 6.4 μL of RNase-Free ddH2O. All reaction was included in one cycle of pre-denaturation at 95 °C for 15 min; fifty cycles of denaturation at 95 °C for 3 s; annealing and extension at 53 °C for 25 s. The Cycle threshold (Ct) values and baseline settings were determined by automatic analysis settings, and the copy numbers of the target group for each reaction were calculated from the standard curves of plasmid DNA produced by a 10-fold serial dilution of (1 × 101 to 1 × 109 copies/μL).

4.9. Metabolite Concentrations in Cecal Contents

The concentrations of SCFA (acetic acid, propanoic acid, and butyric acid) were determined by a gas chromatograph (VARIAN CP-3800, Varian, Palo Alto, CA, USA; capillary column 30 m × 0.32 mm × 0.25 μm film thickness) according to the previous method [61]. After centrifuging (12,000× g for 10 min), the supernatant was mixed with 0.2 mL metaphosphoric acid and 23.3 μL 210 mmol/L crotonic acid in a new tube, and those mixtures were centrifuged in the same conditions again after 30 min incubation at 4 °C. 1 μL of the supernatant were analyzed through the gas chromatograph. The polyethylene glycol column was operated with highly purified N2 as carrier gas at 1.8 mL/min.

4.10. Isolation and Reverse Transcription of RNA from Intestinal Mucosa and q-PCR

Following the manufacturer’s instructions, total RNA was extracted from a bit of duodenal, jejunal and ileal mucosa samples. All mucosa samples were homogenized with 1 mL of RNAiso Plus (Takara Biotechnology Co., Ltd., Dalian, China), and the concentration and fineness of total RNA were measured by a spectrophotometer (NanoDrop 2000, Thermo Fisher Scientific, Inc., Waltham, MA, USA). Approximately 1 μg total RNA was reverse transcribed into cDNA according to the protocol of the PrimeScript™ RT reagent kit with gDNA Eraser (Takara Biotechnology Co., Ltd., Dalian, China). This process was as follows: (1) 37 °C for 15 min, (2): 85 °C for 5 s. The expression level of the target genes was quantified by q-PCR, and the oligonucleotide primer sequences were shown in Table S1. qPCR was performed with the SYBR® Green PCR I PCR reagents (Takara Bio Inc., Dalian, China) using the same PCR system mentioned above. The reaction mixture (total volume of 10 μL) composed of 5 μL SYBR Premix Ex Taq II (Tli RNaseH Plus), 0.4 μL forward primer and reverse primer, 1 μL cDNA and 3.2 μL RNase-Free ddH2O. The procedure of q-PCR is as follows: 95 °C for 30 s, followed by 40 cycles: at 95 °C for 5 s and 60 °C for 30 s. The mRNA relative expression level of target genes was standardized by the housekeeping gene β-actin, which was calculated based on the 2–ΔΔCt method [62].

4.11. Statistical Analysis

The data was analyzed by two-way ANOVA with the general linear model (GLM) procedure of SPSS as a two (BGL) × 2 (ETEC) factorial design. p-value < 0.05 was considered as significant and the p-value variation from 0.05 to 0.1 was considered as a significant trend. Duncan’s multiple range test was used based on the analysis of ANOVA, which showed a significant difference. All data were analyzed by SPSS 27.0 (IBM, Chicago, IL, USA). Results are expressed as means with their standard errors.

5. Conclusions

In conclusion, our results indicated a positive effect of dietary BGL supplementation on the growth performance and intestinal health in the weaned pigs upon ETEC challenge. The mechanisms behind its action may be connected with the suppressed secretion of inflammatory cytokines, improved immunity and intestinal morphology, as well as changes of the microbial fermentation.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics11040519/s1, Table S1: Primers sequences used for quantitative RT-PCR.

Author Contributions

J.H. conceived and designed the experiments. Y.Z. performed animal trial and wrote the manuscript. B.Y., X.M., P.Z., J.Y., H.Y. and Z.H. performed biochemical analysis. J.L., Y.L. and H.Y. gave constructive comments for the results and discussion of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Key Research and Development Program of Sichuan Province (No. 2020YFN0147) and the National Natural Science Foundation of China (No. 31972599).

Institutional Review Board Statement

The animal experiment was approved by the Institutional Animal Care and Use Committee of Sichuan Agricultural University (No. 20181105).

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank SYNLGHT BIO Co., Ltd. for their generous donation, and Wang Huifen, Wu Fali, and Qiming Duan for their help during the animal trial and sample collections.

Conflicts of Interest

There authors declare that they have no conflict of interest.

References

  1. Campbell, J.M.; Crenshaw, J.D.; Polo, J. The biological stress of early weaned piglets. J. Anim. Sci. Biotechnol. 2013, 4, 19. [Google Scholar] [CrossRef] [Green Version]
  2. Eriksen, E.Ø.; Kudirkiene, E.; Christensen, A.E.; Agerlin, M.V.; Weber, N.R.; Nødtvedt, A.; Nielsen, J.P.; Hartmann, K.T.; Skade, L.; Larsen, L.E.; et al. Post-weaning diarrhea in pigs weaned without medicinal zinc: Risk factors, pathogen dynamics, and association to growth rate. Porc. Health Manag. 2021, 7, 54. [Google Scholar] [CrossRef]
  3. Fairbrother, J.M.; Nadeau, E.; Gyles, C.L. Escherichia coli in postweaning diarrhea in pigs: An update on bacterial types, pathogenesis, and prevention strategies. Anim. Health Res. Rev. 2005, 6, 17–39. [Google Scholar] [CrossRef] [Green Version]
  4. Madhavan, T.P.V.; Sakellaris, H. Colonization factors of enterotoxigenic Escherichia coli. Adv. Appl. Microbiol. 2015, 90, 155–197. [Google Scholar] [CrossRef]
  5. Jensen, M.L.; Thymann, T.; Cilieborg, M.S.; Lykke, M.; Mølbak, L.; Jensen, B.B.; Schmidt, M.; Kelly, D.; Mulder, I.; Burrin, D.G.; et al. Antibiotics modulate intestinal immunity and prevent necrotizing enterocolitis in preterm neonatal piglets. Am. J. Physiol. -Gastrointest. Liver Physiol. 2014, 306, G59–G71. [Google Scholar] [CrossRef] [Green Version]
  6. Sato, H.; Zhang, L.S.; Martinez, K.; Chang, E.B.; Yang, Q.; Wang, F.; Howles, P.N.; Hokari, R.; Miura, S.; Tso, P. Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats. Gastroenterology 2016, 151, 923–932. [Google Scholar] [CrossRef] [Green Version]
  7. Holota, Y.; Dovbynchuk, T.; Kaji, I.; Vareniuk, I.; Dzyubenko, N.; Chervinska, T.; Zakordonets, L.; Stetska, V.; Ostapchenko, L.; Serhiychuk, T.; et al. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity. PLoS ONE 2019, 14, e0220642. [Google Scholar] [CrossRef]
  8. Oberc, A.M.; Fiebig-Comyn, A.A.; Tsai, C.N.; Elhenawy, W.; Coombes, B.K. Antibiotics Potentiate Adherent-Invasive E. coli Infection and Expansion. Inflamm. Bowel Dis. 2019, 25, 711–721. [Google Scholar] [CrossRef]
  9. Tanaka, T.; Narazaki, M.; Kishimoto, T. Interleukin (IL-6) Immunotherapy. Cold Spring Harb. Perspect. Biol. 2018, 10, a028456. [Google Scholar] [CrossRef]
  10. Lordan, C.; Thapa, D.; Ross, R.P.; Cotter, P.D. Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components. Gut Microbes 2020, 11, 1–20. [Google Scholar] [CrossRef] [Green Version]
  11. Duan, X.; Tian, G.; Chen, D.; Huang, L.; Zhang, D.; Zheng, P.; Mao, X.; Yu, J.; He, J.; Huang, Z.; et al. Mannan oligosaccharide supplementation in diets of sow and (or) their offspring improved immunity and regulated intestinal bacteria in piglet1. J. Anim. Sci. 2019, 97, 4548–4556. [Google Scholar] [CrossRef]
  12. Liu, L.; Chen, D.; Yu, B.; Yin, H.; Huang, Z.; Luo, Y.; Zheng, P.; Mao, X.; Yu, J.; Luo, J.; et al. Fructooligosaccharides improve growth performance and intestinal epithelium function in weaned pigs exposed to enterotoxigenic Escherichia coli. Food Funct. 2020, 11, 9599–9612. [Google Scholar] [CrossRef]
  13. Froebel, L.K.; Froebel, L.E.; Duong, T. Refined functional carbohydrates reduce adhesion of Salmonella and Campylobacter to poultry epithelial cells in vitro. Poult. Sci. 2020, 99, 7027–7034. [Google Scholar] [CrossRef]
  14. Adhikari, P.; Cosby, D.E.; Cox, N.A.; Franca, M.S.; Williams, S.M.; Gogal, R.M.; Ritz, C.W.; Kim, W.K. Effect of dietary fructooligosaccharide supplementation on internal organs Salmonella colonization, immune response, ileal morphology, and ileal immunohistochemistry in laying hens challenged with Salmonella enteritidis. Poult. Sci. 2018, 97, 2525–2533. [Google Scholar] [CrossRef]
  15. Yu, E.; Chen, D.; Yu, B.; Huang, Z.; Mao, X.; Zheng, P.; Luo, Y.; Yin, H.; Yu, J.; Luo, J.; et al. Manno-oligosaccharide attenuates inflammation and intestinal epithelium injury in weaned pigs upon enterotoxigenic Escherichia coli K88 challenge. Br. J. Nutr. 2021, 126, 993–1002. [Google Scholar] [CrossRef]
  16. Du, B.; Meenu, M.; Liu, H.; Xu, B. A Concise Review on the Molecular Structure and Function Relationship of β-Glucan. Int. J. Mol. Sci. 2019, 20, 4032. [Google Scholar] [CrossRef] [Green Version]
  17. Das, D.; Baruah, R.; Goyal, A. A food additive with prebiotic properties of an α-d-glucan from lactobacillus plantarum DM5. Int. J. Biol. Macromol. 2014, 69, 20–26. [Google Scholar] [CrossRef]
  18. Wang, H.; Chen, G.; Li, X.; Zheng, F.; Zeng, X. Yeast β-glucan, a potential prebiotic, showed a similar probiotic activity to inulin. Food Funct. 2020, 11, 10386–10396. [Google Scholar] [CrossRef]
  19. Chae, J.S.; Shin, H.; Song, Y.; Kang, H.; Yeom, C.-H.; Lee, S.; Choi, Y.S. Yeast (1 → 3)-(1 → 6)-β-d-glucan alleviates immunosuppression in gemcitabine-treated mice. Int. J. Biol. Macromol. 2019, 136, 1169–1175. [Google Scholar] [CrossRef]
  20. Alexander, M.P.; Fiering, S.N.; Ostroff, G.R.; Cramer, R.A.; Mullins, D.W. Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung. Cancer Immunol. Immunother. 2018, 67, 1731–1742. [Google Scholar] [CrossRef]
  21. Zhen, W.; Shao, Y.; Wu, Y.; Li, L.; van Pham, H.; Abbas, W.; Wan, Z.; Guo, Y.; Wang, Z. Dietary yeast β-glucan supplementation improves eggshell color and fertile eggs hatchability as well as enhances immune functions in breeder laying hens. Int. J. Biol. Macromol. 2020, 159, 607–621. [Google Scholar] [CrossRef] [PubMed]
  22. Volman, J.J.; Ramakers, J.D.; Plat, J. Dietary modulation of immune function by beta-glucans. Physiol. Behav. 2008, 94, 276–284. [Google Scholar] [CrossRef] [PubMed]
  23. Lam, K.-L.; Chi-Keung Cheung, P. Non-digestible long chain beta-glucans as novel prebiotics. Bioact. Carbohydr. Diet. Fibre 2013, 2, 45–64. [Google Scholar] [CrossRef]
  24. Brown, G.D.; Taylor, P.R.; Reid, D.M.; Willment, J.A.; Williams, D.L.; Martinez-Pomares, L.; Wong, S.Y.C.; Gordon, S. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 2002, 196, 407–412. [Google Scholar] [CrossRef] [Green Version]
  25. El Kaoutari, A.; Armougom, F.; Gordon, J.I.; Raoult, D.; Henrissat, B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 2013, 11, 497–504. [Google Scholar] [CrossRef] [PubMed]
  26. Metzler-Zebeli, B.U.; Zebeli, Q. Cereal β-glucan alters nutrient digestibility and microbial activity in the intestinal tract of pigs, and lower manure ammonia emission: A meta-analysis. J. Anim. Sci. 2013, 91, 3188–3199. [Google Scholar] [CrossRef] [PubMed]
  27. Vetvicka, V.; Vannucci, L.; Sima, P.; Richter, J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules 2019, 24, 1251. [Google Scholar] [CrossRef] [Green Version]
  28. Abo Ghanima, M.M.; Abd El-Aziz, A.H.; Noreldin, A.E.; Atta, M.S.; Mousa, S.A.; El-Far, A.H. β-glucan administration improves growth performance and gut health in New Zealand White and APRI rabbits with different breed responses. PLoS ONE 2020, 15, e0234076. [Google Scholar] [CrossRef]
  29. Zhu, M.; Wu, S. The growth performance and nonspecific immunity of loach Paramisgurnus dabryanus as affected by dietary β-1,3-glucan. Fish Shellfish Immunol. 2018, 83, 368–372. [Google Scholar] [CrossRef]
  30. Teng, P.-Y.; Adhikari, R.; Llamas-Moya, S.; Kim, W.K. Effects of combination of mannan-oligosaccharides and β-glucan on growth performance, intestinal morphology, and immune gene expression in broiler chickens. Poult. Sci. 2021, 100, 101483. [Google Scholar] [CrossRef]
  31. Markina, Y.V.; Gerasimova, E.V.; Markin, A.M.; Glanz, V.Y.; Wu, W.-K.; Sobenin, I.A.; Orekhov, A.N. Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases. Int. J. Mol. Sci. 2020, 21, 5472. [Google Scholar] [CrossRef] [PubMed]
  32. Bournazos, S.; Ravetch, J.V. Diversification of IgG effector functions. Int. Immunol. 2017, 29, 303–310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Schroeder, H.W.; Cavacini, L. Structure and function of immunoglobulins. J. Allergy Clin. Immunol. 2010, 125, S41–S52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Ljuca, F.; Gegic, A.; Salkic, N.N.; Pavlovic-Calic, N. Circulating cytokines reflect mucosal inflammatory status in patients with Crohn’s disease. Dig. Dis. Sci. 2010, 55, 2316–2326. [Google Scholar] [CrossRef] [PubMed]
  35. Ji, F.J.; Wang, L.X.; Yang, H.S.; Hu, A.; Yin, Y.L. Review: The roles and functions of glutamine on intestinal health and performance of weaning pigs. Animal 2019, 13, 2727–2735. [Google Scholar] [CrossRef] [Green Version]
  36. Xia, L.; Yang, Y.; Wang, J.; Jing, Y.; Yang, Q. Impact of TGEV infection on the pig small intestine. Virol. J. 2018, 15, 102. [Google Scholar] [CrossRef]
  37. Wu, T.; Shi, Y.; Zhang, Y.; Zhang, M.; Zhang, L.; Ma, Z.; Zhao, D.; Wang, L.; Yu, H.; Hou, Y.; et al. Lactobacillus rhamnosus LB1 Alleviates Enterotoxigenic Escherichia coli-Induced Adverse Effects in Piglets by Improving Host Immune Response and Anti-Oxidation Stress and Restoring Intestinal Integrity. Front. Cell. Infect. Microbiol. 2021, 11, 724401. [Google Scholar] [CrossRef]
  38. Kim, S.J.; Kwon, C.H.; Park, B.C.; Lee, C.Y.; Han, J.H. Effects of a lipid-encapsulated zinc oxide dietary supplement, on growth parameters and intestinal morphology in weanling pigs artificially infected with enterotoxigenic Escherichia coli. J. Anim. Sci. Technol. 2015, 57, 4. [Google Scholar] [CrossRef] [Green Version]
  39. Roberts, C.L.; Keita, A.V.; Parsons, B.N.; Prorok-Hamon, M.; Knight, P.; Winstanley, C.; O’ Kennedy, N.; Söderholm, J.D.; Rhodes, J.M.; Campbell, B.J. Soluble plantain fibre blocks adhesion and M-cell translocation of intestinal pathogens. J. Nutr. Biochem. 2013, 24, 97–103. [Google Scholar] [CrossRef] [Green Version]
  40. Shoaf, K.; Mulvey, G.L.; Armstrong, G.D.; Hutkins, R.W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect. Immun. 2006, 74, 6920–6928. [Google Scholar] [CrossRef] [Green Version]
  41. Wan, J.; Zhang, J.; Xu, Q.; Yin, H.; Chen, D.; Yu, B.; He, J. Alginate oligosaccharide protects against enterotoxigenic Escherichia coli-induced porcine intestinal barrier injury. Carbohydr. Polym. 2021, 270, 118316. [Google Scholar] [CrossRef] [PubMed]
  42. Stüber, E.; Büschenfeld, A.; von Freier, A.; Arendt, T.; Fölsch, U.R. Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: Effect of pentoxifylline on the development of mucosal atrophy. Gut 1999, 45, 229–235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Ulluwishewa, D.; Anderson, R.C.; McNabb, W.C.; Moughan, P.J.; Wells, J.M.; Roy, N.C. Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 2011, 141, 769–776. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Suzuki, T. Regulation of intestinal epithelial permeability by tight junctions. Cell. Mol. Life Sci. 2013, 70, 631–659. [Google Scholar] [CrossRef] [PubMed]
  45. Furuse, M.; Hata, M.; Furuse, K.; Yoshida, Y.; Haratake, A.; Sugitani, Y.; Noda, T.; Kubo, A.; Tsukita, S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from claudin-1-deficient mice. J. Cell Biol. 2002, 156, 1099–1111. [Google Scholar] [CrossRef]
  46. Saito, A.C.; Higashi, T.; Fukazawa, Y.; Otani, T.; Tauchi, M.; Higashi, A.Y.; Furuse, M.; Chiba, H. Occludin and tricellulin facilitate formation of anastomosing tight-junction strand network to improve barrier function. Mol. Biol. Cell 2021, 32, 722–738. [Google Scholar] [CrossRef]
  47. Bergstrom, K.S.B.; Kissoon-Singh, V.; Gibson, D.L.; Ma, C.; Montero, M.; Sham, H.P.; Ryz, N.; Huang, T.; Velcich, A.; Finlay, B.B.; et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 2010, 6, e1000902. [Google Scholar] [CrossRef]
  48. Rajapakse, N.W.; Nanayakkara, S.; Kaye, D.M. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment. Pharmacol. Ther. 2015, 154, 1–12. [Google Scholar] [CrossRef]
  49. Persaud, A.; Cormerais, Y.; Pouyssegur, J.; Rotin, D. Dynamin inhibitors block activation of mTORC1 by amino acids independently of dynamin. J. Cell Sci. 2018, 131, jcs211755. [Google Scholar] [CrossRef] [Green Version]
  50. Zhan, T.; Poppelreuther, M.; Ehehalt, R.; Füllekrug, J. Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 increase the cellular fatty acid uptake of 3T3-L1 adipocytes but are localized on intracellular membranes. PLoS ONE 2012, 7, e45087. [Google Scholar] [CrossRef]
  51. Alessi, A.M.; Gray, V.; Farquharson, F.M.; Flores-López, A.; Shaw, S.; Stead, D.; Wegmann, U.; Shearman, C.; Gasson, M.; Collie-Duguid, E.S.R.; et al. β-Glucan is a major growth substrate for human gut bacteria related to Coprococcus eutactus. Environ. Microbiol. 2020, 22, 2150–2164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Ya, T.; Zhang, Q.; Chu, F.; Merritt, J.; Bilige, M.; Sun, T.; Du, R.; Zhang, H. Immunological evaluation of Lactobacillus casei Zhang: A newly isolated strain from koumiss in Inner Mongolia, China. BMC Immunol. 2008, 9, 68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Rocha-Ramírez, L.M.; Hernández-Ochoa, B.; Gómez-Manzo, S.; Marcial-Quino, J.; Cárdenas-Rodríguez, N.; Centeno-Leija, S.; García-Garibay, M. Evaluation of Immunomodulatory Activities of the Heat-Killed Probiotic Strain Lactobacillus casei IMAU60214 on Macrophages In Vitro. Microorganisms 2020, 8, 79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Ho Do, M.; Seo, Y.S.; Park, H.-Y. Polysaccharides: Bowel health and gut microbiota. Crit. Rev. Food Sci. Nutr. 2021, 61, 1212–1224. [Google Scholar] [CrossRef] [PubMed]
  55. Lackraj, T.; Kim, J.I.; Tran, S.-L.; Barnett Foster, D.E. Differential modulation of flagella expression in enterohaemorrhagic Escherichia coli O157: H7 by intestinal short-chain fatty acid mixes. Microbiology 2016, 162, 1761–1772. [Google Scholar] [CrossRef]
  56. Mamuad, L.L.; Kim, S.H.; Choi, Y.J.; Soriano, A.P.; Cho, K.K.; Lee, K.; Bae, G.S.; Lee, S.S. Increased propionate concentration in Lactobacillus mucosae-fermented wet brewers grains and during in vitro rumen fermentation. J. Appl. Microbiol. 2017, 123, 29–40. [Google Scholar] [CrossRef]
  57. Xia, Z.; Han, Y.; Wang, K.; Guo, S.; Wu, D.; Huang, X.; Li, Z.; Zhu, L. Oral administration of propionic acid during lactation enhances the colonic barrier function. Lipids Health Dis. 2017, 16, 62. [Google Scholar] [CrossRef] [Green Version]
  58. National Research Council (U.S.). Nutrient Requirements of Swine, 11th ed.; National Academies Press: Washington, DC, USA, 2012; ISBN 9780309224239. [Google Scholar]
  59. Horwitz, W. Official Methods of Analysis of AOAC International, 18th ed.; Horwitz, W., Latimer, G.W., Eds.; AOAC International: Gaithersburg, MD, USA, 2000. [Google Scholar]
  60. Wan, J.; Zhang, J.; Chen, D.; Yu, B.; Mao, X.; Zheng, P.; Yu, J.; Luo, J.; He, J. Alginate oligosaccharide-induced intestinal morphology, barrier function and epithelium apoptosis modifications have beneficial effects on the growth performance of weaned pigs. J. Anim. Sci. Biotechnol. 2018, 9, 58. [Google Scholar] [CrossRef] [Green Version]
  61. Franklin, M.A.; Mathew, A.G.; Vickers, J.R.; Clift, R.A. Characterization of microbial populations and volatile fatty acid concentrations in the jejunum, ileum, and cecum of pigs weaned at 17 vs. 24 days of age. J. Anim. Sci. 2002, 80, 2904–2910. [Google Scholar] [CrossRef]
  62. Fleige, S.; Walf, V.; Huch, S.; Prgomet, C.; Sehm, J.; Pfaffl, M.W. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol. Lett. 2006, 28, 1601–1613. [Google Scholar] [CrossRef]
Figure 1. Effect of BGL on serum immunogloblins and inflammatory cytokines in weaned pigs upon ETEC challenge TNF-α, tumor necrosis factor-α; IL-1β, interleukin1-β; IL-6, interleukin-6; IgA, immunoglobulins A; IgG, immunoglobulins G; IgM, immunoglobulins M. a, b, c mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet (500 mg/kg); ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Figure 1. Effect of BGL on serum immunogloblins and inflammatory cytokines in weaned pigs upon ETEC challenge TNF-α, tumor necrosis factor-α; IL-1β, interleukin1-β; IL-6, interleukin-6; IgA, immunoglobulins A; IgG, immunoglobulins G; IgM, immunoglobulins M. a, b, c mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet (500 mg/kg); ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Antibiotics 11 00519 g001
Figure 2. Effect of BGL supplementation on intestinal morphology in weaned pigs upon ETEC challenge (H&E; × 40) CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet, 500 mg/kg; ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC. Duodenum, jejunum and ileum in the CON group revealed a normal appearance with regular intestinal villus structure; duodenum, jejunum and ileum in the BGL group, no obvious damages were found. However, in the ECON group, the intestinal lesions were obvious and some intestinal villi were necrotic and shed, or even disappeared, especially in the jejunum; in the duodenum, jejunum and ileum in the EBGL group there were no obvious intestinal lesions and only a few of the intestinal villi were necrotic and shed.
Figure 2. Effect of BGL supplementation on intestinal morphology in weaned pigs upon ETEC challenge (H&E; × 40) CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet, 500 mg/kg; ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC. Duodenum, jejunum and ileum in the CON group revealed a normal appearance with regular intestinal villus structure; duodenum, jejunum and ileum in the BGL group, no obvious damages were found. However, in the ECON group, the intestinal lesions were obvious and some intestinal villi were necrotic and shed, or even disappeared, especially in the jejunum; in the duodenum, jejunum and ileum in the EBGL group there were no obvious intestinal lesions and only a few of the intestinal villi were necrotic and shed.
Antibiotics 11 00519 g002
Figure 3. Effect of BGL supplementation on mucosal gene expressions in weaned pigs upon ETEC challenge ZO-1, zonula occludens-1. SGLT-1, sodium/glucose cotransporter-1; CAT-1, cationic amino acid transporter-1; LAT-1, L amino acid transporter-1; FATP, fatty acid transport proteins; a, b, c mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet, 500 mg/kg; ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Figure 3. Effect of BGL supplementation on mucosal gene expressions in weaned pigs upon ETEC challenge ZO-1, zonula occludens-1. SGLT-1, sodium/glucose cotransporter-1; CAT-1, cationic amino acid transporter-1; LAT-1, L amino acid transporter-1; FATP, fatty acid transport proteins; a, b, c mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet, 500 mg/kg; ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Antibiotics 11 00519 g003
Table 1. Effect of BGL supplementation on ADFI and ADG in weaned pigs upon ETEC challenge.
Table 1. Effect of BGL supplementation on ADFI and ADG in weaned pigs upon ETEC challenge.
ITEMTreatmentsSEMp-Value
CONBGLECONEBGLBGLETECInteraction
1–25 d
ADFI (g/d)427.11429.16459.58459.7722.47
ADG (g/d)280.47267.2286.48302.1315.61
F: G1.581.621.561.550.04
25–28 d
ADFI (g)631.68602.26537.85597.2224.960.780.350.4
ADG (g)519.9 a476.67 ab361.33 b511.11 ab27.90.310.240.08
F: G1.251.31.531.240.070.390.410.22
ADFI, average daily feed intake; ADG, average daily gain; F: G, feed: gain ratio. Mean and total SEM are listed in separate columns (n = 8). a, b mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL, pigs were fed with a BGL containing diet (500 mg/kg); ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Table 2. Effect of BGL supplementation on nutrients digestibility in weaned pigs.
Table 2. Effect of BGL supplementation on nutrients digestibility in weaned pigs.
ITEMTreatmentsSEMp-Value
CONBGLECONEBGL
DM (%)88.4388.6988.9889.170.400.93
CP (%)86.5386.4987.1887.620.680.93
EE (%)84.9684.8986.3486.560.580.65
Ash (%)67.6570.669.5570.910.860.58
GE (%)88.5688.7689.1789.270.430.94
DM, dry matter; CP, crude protein; EE, ether extract; GE, gross energy. Mean and total SEM are list in separate columns (n = 8). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet (500 mg/kg); ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Table 3. Effect of BGL supplementation on intestinal morphology in weaned pigs upon ETEC challenge.
Table 3. Effect of BGL supplementation on intestinal morphology in weaned pigs upon ETEC challenge.
ITEMTreatmentsSEMp-Value
CONBGLECONEBGLBGLETECInteraction
Duodenum
Villus height, μm402.98 ab461.37 a378.85 b454.45 a13.790.020.550.74
Crypt depth, μm135.42139.42156.99154.575.40.950.10.78
V:C3.12 ab3.52 a2.73 b 3.19 ab0.120.070.120.92
Jejunum
Villus height, μm413.89 a442.74 a299.70 b423.62 a13.68<0.01<0.01<0.01
Crypt depth, μm137.96123.95144.87126.525.340.150.670.84
V:C3.11 ab3.50 a2.62 b3.45 a0.120.010.220.33
Ileum
Villus height, μm318.70 ab340.07 a265.98 b344.75 a10.870.010.210.14
Crypt depth, μm137.96123.95144.87126.525.340.150.670.84
V:C2.42 ab3.05 a2.23 b2.79 ab0.140.040.420.9
V:C, Villus height: Crypt depth. Mean and total SEM are listed in separate columns (n = 8). a, b mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet (500 mg/kg); ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Table 4. Effect of BGL supplementation on mucosal enzyme activity in weaned pigs upon ETEC challenge.
Table 4. Effect of BGL supplementation on mucosal enzyme activity in weaned pigs upon ETEC challenge.
ITEMTreatmentsSEMp-Value
CONBGLECONEBGLBGLETECInteraction
Duodenum
Lactase (U/L)78.59 a66.08 c72.92 b66.03 c1.420.0010.0060.001
Sucrase (U/L)255.48 a254.47 a234.90 b264.43 a2.760.0010.16<0.01
Maltase (U/L)175.56 c188.19 b166.91 d197.63 a2.820.030.88<0.01
Jejunum
Lactase (U/L)107.58 a103.48 a93.15 b102.80 a1.770.0010.130.14
Sucrase (U/L)353.32 a352.25 a328.36 b368.95 a4.430.010.560.07
Maltase (U/L)286.45 b290.57 ab274.63 c298.55 a2.36<0.010.570.007
Ileum
Lactase (U/L)39.85 a40.21 a31.15 b32.09 b1.220.72<0.010.87
Sucrase (U/L)294.08 bc315.82 a283.07 c306.39 ab3.27<0.010.030.86
Maltase (U/L)214.18 c229.17 b202.78 c243.26 a3.77<0.010.760.008
Mean and total SEM are listed in separate columns (n = 8). a, b, c, d mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet (500 mg/kg); ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Table 5. Effect of BGL supplementation on intestinal microbiota and microbial metabolites in weaned pigs upon ETEC challenge.
Table 5. Effect of BGL supplementation on intestinal microbiota and microbial metabolites in weaned pigs upon ETEC challenge.
ITEMTreatmentsSEMp-Value
CONBGLECONEBGLBGLETECInteraction
microbial populations (lg(copies/g))
Total bacteria11.1811.0311.1811.210.050.50.350.34
Escherichia coli8.35 b8.14 b9.88 a9.50 a0.220.420.0010.81
Lactobacillus8.28 ab8.75 a7.93 b8.60 a0.10.0040.170.58
Bifidobacterium6.096.286.26.090.130.880.880.59
Bacillus9.169.189.099.030.040.80.180.6
VFA (g/g)
Acetic acid3.36 ab3.65 a2.59 b3.14 ab0.190.250.090.72
Propanoic acid1.73 ab1.74 ab1.40 b2.00 a0.090.070.830.08
Butyric acid0.780.950.820.780.050.590.60.41
VFA, volatile fatty acids. Mean and total SEM are listed in separate columns (n = 8). a, b mean values within a row with unlike superscript letters were significantly different (p < 0.05). CON pigs were fed with a basal diet; BGL pigs were fed with a BGL containing diet (500 mg/kg); ECON pigs were fed with a basal diet and challenged by ETEC; EBGL pigs were fed with a BGL containing diet (500 mg/kg) and challenged by ETEC.
Table 6. Experiment basal diet composition and nutrient level.
Table 6. Experiment basal diet composition and nutrient level.
Ingredients%Nutrient LevelContents
Corn28.31Digestible energy (calculated, MJ/kg)14.78
Extruded corn24.87Crude Protein (%)19.68
Soybean meal8.5Calcium (%)0.81
Extruded full-fat soybean10.3Available phosphorus (%)0.55
Fish meal4.2Lysine1.35
Whey powder7Methionine0.42
Soybean protein concentrate8Methionine + cysteine0.6
Soybean oil2Threonine0.79
Sucrose4Tryptophan0.22
Limestone0.9
Dicalcium phosphate0.5
NaCl0.3
L-Lysine HCl (78%)0.47
DL-Methionine0.15
L-Threonine (98.5%)0.13
Tryptophan (98%)0.03
Chloride choline0.1
Vitamin premix 10.04
Mineral premix 20.2
Total100
1 The vitamin premix provided the following per kg of diet: 9000 IU of VA, 3000 IU of VD 3, 20 IU of VE, 3 mg of VK 3, 1.5 mg of VB1, 4 mg of VB 2, 3 mg of VB6, 0.02 mg of VB12, 30 mg of niacin, 15 mg of pantothenic acid, 0.75 mg of folic acid, and 0.1 mg of biotin. 2 The mineral premix provided the following per kg of diet: 100 mg Fe, 6 mg Cu, 100 mg Zn, 4 mg Mn, 0.30 mg I, 0.3 mg Se. The diet was formulated based on the recommendation of NRC2012.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zhou, Y.; Luo, Y.; Yu, B.; Zheng, P.; Yu, J.; Huang, Z.; Mao, X.; Luo, J.; Yan, H.; He, J. Effect of β-Glucan Supplementation on Growth Performance and Intestinal Epithelium Functions in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli. Antibiotics 2022, 11, 519. https://doi.org/10.3390/antibiotics11040519

AMA Style

Zhou Y, Luo Y, Yu B, Zheng P, Yu J, Huang Z, Mao X, Luo J, Yan H, He J. Effect of β-Glucan Supplementation on Growth Performance and Intestinal Epithelium Functions in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli. Antibiotics. 2022; 11(4):519. https://doi.org/10.3390/antibiotics11040519

Chicago/Turabian Style

Zhou, Yuankang, Yuheng Luo, Bing Yu, Ping Zheng, Jie Yu, Zhiqing Huang, Xiangbing Mao, Junqiu Luo, Hui Yan, and Jun He. 2022. "Effect of β-Glucan Supplementation on Growth Performance and Intestinal Epithelium Functions in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli" Antibiotics 11, no. 4: 519. https://doi.org/10.3390/antibiotics11040519

APA Style

Zhou, Y., Luo, Y., Yu, B., Zheng, P., Yu, J., Huang, Z., Mao, X., Luo, J., Yan, H., & He, J. (2022). Effect of β-Glucan Supplementation on Growth Performance and Intestinal Epithelium Functions in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli. Antibiotics, 11(4), 519. https://doi.org/10.3390/antibiotics11040519

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop